Treatment with a dual amylin and calcitonin receptor agonist improves metabolic health in an old, obese, and ovariectomized rat model

OBJECTIVES: Menopause is often characterized by detrimental metabolic changes, such as obesity, insulin resistance, and impaired glucose tolerance, often requiring treatment. KeyBioscience Peptides (KBPs) are Dual Amylin and Calcitonin Receptor Agonists which have shown promising metabolic effects i...

Full description

Saved in:
Bibliographic Details
Published in:Menopause
Main Authors: Katri, Anna, Reker, Ditte, Karsdal, Morten A., Bay-Jensen, Anne-Christine, Henriksen, Kim
Format: Artigo
Language:Inglês
Published: Lippincott Williams & Wilkins 2021
Subjects:
Original Studies
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8284344/
https://ncbi.nlm.nih.gov/pubmed/33399320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GME.0000000000001722
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items